Treatment of Tularemia in Pregnancy
Tularemia during pregnancy presents a distinct clinical challenge: effective antimicrobial therapy must be chosen with both maternal and fetal safety in mind, and standard options for the general population do not all apply equally in this setting.
Clinical Scenario
This protocol applies to pregnant women diagnosed with tularemia in any clinical form. Pregnancy alters drug pharmacokinetics and restricts certain antimicrobial choices, making agent selection and dosing strategy specific to this population.
Treatment Approach
First-line management is built around a fluoroquinolone or an aminoglycoside, each evaluated for suitability in pregnancy. For severe disease, a specific dual-class combination is preferred, with guidance on route of administration and when to transition therapy.
Full regimen details — including agent selection, dosing strategy, severity thresholds, and sequencing — are available in the protocol.
References
For pregnant women with any form of tularemia, fluoroquinolones (i.e., ciprofloxacin or levofloxacin) or gentamicin are recommended for first-line treatment.
Dual therapy with distinct antimicrobial classes is recommended for treatment of severe tularemia during pregnancy.
View source ↗